{
  "score_after": {
    "hsef_level": "Γ",
    "hsef_descriptor": "Mechanistically plausible, partial system support",
    "confidence": "Moderate",
    "confidence_rationale": "61 primary reports with 3 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "Overall Γ applies to SC3. Context-specific animal function/survival and genuine prevention of diabetes do not establish generalized human aging slowing. The strongest model results are retained at Ε within their tested settings, with dose, timing, sex, diet and statistical boundaries explicit."
  },
  "primary_comparisons": [
    {
      "doi": "10.1016/j.eclinm.2026.103874",
      "study_group": "METFORAGING",
      "access_depth": "Original primary abstract and full-text passages; newly published within cutoff, supplemental, outside original ledger",
      "pmid": "42023167",
      "result_comparison": "40 older non-diabetic adults with HIV randomized; n=35 completed; primary PhenoAge EAA difference -1.02 years (95% CI -5.30 to 3.26; p=.627); no significant between-group epigenetic biomarker differences; no healthspan endpoint.",
      "source_type": "primary study report"
    },
    {
      "doi": "10.1093/gerona/glaa295",
      "study_group": "DPP_DPPOS",
      "access_depth": "Original primary published report abstract; frozen source ledger",
      "pmid": "33428709",
      "result_comparison": "Published frailty outcome in diabetes prevention follow-up; narrow prediabetes context and no generalized aging proof. Consensus review relied partly on old preliminary framing; published primary source already present.",
      "source_type": "primary study report"
    },
    {
      "doi": "10.64898/2026.07.27.26359055",
      "study_group": "NCT02570672",
      "access_depth": "medRxiv preprint abstract/full text and registered protocol; explicitly unreviewed; supplemental outside original 61",
      "pmid": "42620010",
      "result_comparison": "Older adults with prediabetes/glucose intolerance randomized; primary Fried frailty outcome not clearly positive and year-1 result driven by weight-loss item; secondary FI modestly improved. Narrow Δ signal cannot establish broad non-diabetic geroprotection; would impose Low confidence if final grading rested on it.",
      "source_type": "primary study report"
    }
  ],
  "grade_changed": false,
  "raw_paths": [
    "consensus-browser-response.md",
    "browser-thread.json",
    "consensus-search-raw.json",
    "consensus-fetch-1a8ceb62113b58db9503e31eab8fe509.json"
  ],
  "queries": [
    "metformin effects on human aging (browser request in browser-thread.json)",
    "human:true metformin geroprotection healthy non-diabetic older adults randomized TAME",
    "supplemental registered older-adult prediabetes frailty trial protocol/result search"
  ],
  "cutoff": "2026-10-09",
  "score_before": {
    "hsef_level": "Γ",
    "hsef_descriptor": "Mechanistically plausible, partial system support",
    "confidence": "Moderate",
    "confidence_rationale": "61 primary reports with 3 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
    "rests_on_non_peer_reviewed_work": false,
    "rationale": "Overall Γ applies to SC3. Context-specific animal function/survival and genuine prevention of diabetes do not establish generalized human aging slowing. The strongest model results are retained at Ε within their tested settings, with dose, timing, sex, diet and statistical boundaries explicit."
  },
  "conclusion": "METFORAGING is a small biomarker pilot with an imprecise null. The prediabetes frailty preprint has a null/weight-driven primary functional outcome and a modest secondary FI signal. Neither crosses broad SC3; both supplements remain outside original count.",
  "addendum_path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\addendum.md",
  "original_counts_preserved": {
    "claims_total": 65,
    "sources_total": 61
  },
  "completed": true,
  "independent_blinded_audit": false,
  "provider_mode": "Consensus Pro browser thread plus Consensus keyword search/fetch; supplemental PubMed/protocol check",
  "primary_comparison_count": 3,
  "protocol_sources": [
    {
      "role": "Confirms endpoint hierarchy; not an outcome report and not counted as a primary result or report.",
      "source_type": "registered protocol",
      "doi": "10.1093/gerona/glz069"
    }
  ],
  "secondary_comparisons": [
    {
      "pmid": "36281624",
      "doi": "10.1111/acel.13733",
      "source_type": "secondary systematic review/meta-analysis; not primary",
      "access_depth": "Consensus-cited systematic review; abstract/full-text appraisal bounded; absent from frozen selected-records primary report ledger",
      "study_group": "animal lifespan systematic review",
      "result_comparison": "Heterogeneous lifespan effects; no significant overall lifespan extension in mice or nematodes, with subgroup-specific worm findings. Secondary synthesis relevant to SC2, not an original primary comparison and not evidence for SC3."
    }
  ],
  "source_id_reconciliation": [
    {
      "study_group": "METFORAGING",
      "status": "absent",
      "id": "PMID 42023167 / DOI 10.1016/j.eclinm.2026.103874",
      "location": "supplemental primary RCT report, within cutoff"
    },
    {
      "study_group": "DPP_DPPOS",
      "status": "present",
      "id": "PMID 33428709 / DOI 10.1093/gerona/glaa295",
      "location": "selected-records.json/evidence; original report"
    },
    {
      "study_group": "animal lifespan synthesis",
      "status": "absent",
      "id": "PMID 36281624 / DOI 10.1111/acel.13733",
      "location": "secondary systematic review/meta-analysis; not a primary report"
    },
    {
      "study_group": "NCT02570672",
      "status": "absent",
      "id": "PMID 42620010 / DOI 10.64898/2026.07.27.26359055",
      "location": "supplemental non-peer-reviewed preprint, within cutoff"
    },
    {
      "study_group": "NCT02570672",
      "status": "absent",
      "id": "DOI 10.1093/gerona/glz069",
      "location": "registered trial protocol; design/endpoint source only, not an outcome report or primary report count unit"
    }
  ],
  "additional_original_source_receipts": [],
  "status": "completed_retrospective_original_source_reconciliation",
  "raw_receipts": [
    {
      "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\consensus-browser-response.md",
      "sha256": "6b0fc53b4b80c39b9a4068ba1fa84d4a4385e960278b1c2f3c3f23206dde578f"
    },
    {
      "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\browser-thread.json",
      "sha256": "970e60134102ce74ece153d437ca2d3ef5822b92a5e548946584146a40917e9a"
    },
    {
      "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\consensus-search-raw.json",
      "sha256": "b61712e145bedbae262f41de9b0ed948d447c58419e446cf315b60d7aa92f03f"
    },
    {
      "path": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\consensus-fetch-1a8ceb62113b58db9503e31eab8fe509.json",
      "sha256": "ae7bc70d3669e327b19d3e3075b090a266cfd058c6a4aede03ae4f5e417b30fe"
    }
  ],
  "manifest_source": "deliverables\\consensus_consistency_audit_2026-10-09\\checks\\metformin-geroprotection\\final-structured-consensus-validation.json",
  "literature_cutoff_preserved": true
}